Titre:
  • Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: The adjuvant lapatinib and/or trastuzumab treatment optimization experience
Auteur:Metzger-Filho, Otto; Azambuja, Evandro; Bradbury, Ian; Saini, Kamal; Bines, Jose; Simon, Sergio; van Dooren, Veerle; Aktan, Gursel; Pritchard, Kathleen; Wolff, Antonio A.C.; Smith, Ian; Jackisch, Christian; Lang, Istvan; Untch, Michael; Boyle, Frances; Xu, Binghe; Baselga, José; Perez, Edith A; Piccart-Gebhart, Martine
Informations sur la publication:The oncologist, 18, 2, page (134-140)
Statut de publication:Publié, 2013
Sujet CREF:Cancérologie
Mots-clés:Activation
Ethics committee/institutional review board
Phase III clinical trials
MeSH keywords:Antibodies, Monoclonal, Humanized -- administration & dosage -- therapeutic use
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast Neoplasms -- drug therapy -- pathology
Clinical Trials, Phase III as Topic -- methods
Female
Humans
International Cooperation
Multicenter Studies as Topic -- methods
Quinazolines -- administration & dosage
Randomized Controlled Trials as Topic -- methods
Time Factors
Note générale:SCOPUS: re.j
Langue:Anglais
Identificateurs:urn:issn:1083-7159
info:doi/10.1634/theoncologist.2012-0342
info:pii/theoncologist.2012-0342
info:scp/84874350918
info:pmid/23359433